What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary scientific interests are in Breast cancer, Cancer research, Gene, Genetics and Cancer.
His Breast cancer study is focused on Internal medicine in general.
Charles M. Perou has included themes like DNA methylation, Gene expression profiling, Carcinoma, microRNA and Cell cycle in his Cancer research study.
His Gene expression profiling study combines topics in areas such as Mesenchymal Glioblastoma, DNA microarray and Cell.
His study on Gene is mostly dedicated to connecting different topics, such as Molecular biology.
Charles M. Perou frequently studies issues relating to Computational biology and Genetics.
His most cited work include:
- Molecular portraits of human breast tumours (11695 citations)
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (8716 citations)
- Comprehensive molecular portraits of human breast tumours (7253 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Cancer research, Oncology and Cancer.
His Breast cancer research includes themes of Immunohistochemistry, Pathology, Gene expression profiling and Bioinformatics.
His Cancer research research incorporates themes from Mutation, Gene expression, Gene, Carcinogenesis and Mammary tumor.
His specific area of interest is Gene, where Charles M. Perou studies Transcriptome.
The Oncology study combines topics in areas such as Neoadjuvant therapy, Taxane, Chemotherapy, Docetaxel and Carboplatin.
His Cancer study is associated with Genetics.
He most often published in these fields:
- Breast cancer (52.74%)
- Internal medicine (34.15%)
- Cancer research (33.86%)
What were the highlights of his more recent work (between 2017-2021)?
- Breast cancer (52.74%)
- Internal medicine (34.15%)
- Oncology (31.12%)
In recent papers he was focusing on the following fields of study:
Charles M. Perou mainly focuses on Breast cancer, Internal medicine, Oncology, Cancer research and Cancer.
Charles M. Perou studies Triple-negative breast cancer which is a part of Breast cancer.
His work is dedicated to discovering how Oncology, Chemotherapy are connected with Tumor microenvironment and other disciplines.
Charles M. Perou combines subjects such as Mutation, Gene, Carcinogenesis and Immune system, Immunotherapy with his study of Cancer research.
Charles M. Perou mostly deals with Trastuzumab in his studies of Cancer.
He works in the field of Gene expression, focusing on Gene expression profiling in particular.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial (282 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His scientific interests lie mostly in Breast cancer, Oncology, Internal medicine, Cancer research and Gene.
His Breast cancer study incorporates themes from Surgical oncology, Clinical trial and Gene expression profiling.
His Gene expression profiling research incorporates elements of Exome sequencing, Transcriptome and Mrna profiling.
His research integrates issues of Germline mutation and Molecular marker in his study of Internal medicine.
Charles M. Perou has researched Cancer research in several fields, including Mutation, Oncogene, Transcription factor, microRNA and Metastasis.
His work in the fields of Gene, such as DNA microarray and Mutation rate, overlaps with other areas such as Characterization and Confusion.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
